Halyard Health (HYH) Reports Q1 Beat on Revenues

Halyard Health (NYSE: HYH) reported Q1 EPS of $0.76, versus $0.17 reported last year. Revenue for the quarter came in at $156.4 million versus the consensus estimate of $152.97 million.

First Quarter 2018 Financial Highlights

• First quarter continuing operations, or Medical Device sales, were $156 million, a 7 percent increase from the prior year. On a constant currency basis, sales increased 6 percent.
• Net income for the first quarter was $20 million, compared to $13 million in the prior year. Adjusted net income was $36 million, up from $23 million a year ago. Additionally, Medical Device operating profit for the first quarter increased 6 percent to $40 million.
• First quarter diluted earnings per share totaled $0.43, compared to $0.27 a year ago.
• Adjusted diluted earnings per share were $0.76, up 58 percent compared to the prior year.
• First quarter EBITDA was $42 million compared to $43 million in the prior year. On an adjusted basis, EBITDA increased 12 percent to $59 million for the quarter, compared to the prior year.

For earnings history and earnings-related data on Halyard Health (HYH) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c